Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY12 | Q9H244 | 7/20 | 0.40 |
| ▸ | AHCY | P23526 | 1/20 | 0.40 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26533850 | 0.93 | ADORA3 (0.41) | P2RY12PRMT6 | |
| SCHEMBL25496027 | 0.84 | AHCY (0.59) | AHCY | |
| SCHEMBL26327164 | 0.84 | AHCY (0.59) | AHCY | |
| SCHEMBL21504639 | 0.82 | PI4KA (0.52) | P2RY12PRMT6 | |
| SCHEMBL26937492 | 0.82 | PI4KA (0.52) | P2RY12PRMT6 | |
| SCHEMBL26361740 | 0.82 | PI4KA (0.52) | P2RY12PRMT6 | |
| SCHEMBL25751718 | 0.80 | P2RY12 (0.39) | P2RY12AHCY | |
| SCHEMBL24205296 | 0.79 | PRMT6 (0.43) | P2RY12PRMT6 | |
| SCHEMBL26366055 | 0.79 | PRMT6 (0.42) | P2RY12PRMT6 | |
| SCHEMBL26298194 | 0.78 | P2RY1 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11787833-B2 | Modified cyclic dinucleoside compounds as sting modulators | ALIGOS THERAPEUTICS, INC. (US) | 2023-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11787833-B2 | Modified cyclic dinucleoside compounds as sting modulators | STING1, CGAS, IRF3 | P2RY12 366/4885AHCY 4633/4885PRMT6 1677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.